GABRIEL RENE SCOTT
Allopathic & Osteopathic Physicians|Ophthalmology ASHEVILLE, NC NPI 1013445410
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology NC Lumenis BE inc All categories
General Payments — all program years on this page
$4,523.83
- Category: General Payments
- Program years: PY2018–2024
- Record count: 44
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,514.98 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,514.98 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lumenis BE inc | $1,178.89 | 1 |
| Alcon Laboratories Inc | $122.19 | 1 |
| Tarsus Pharmaceuticals, Inc. | $109.56 | 3 |
| Galderma Laboratories, L.P. | $56.84 | 1 |
| Amgen Inc. | $47.50 | 2 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1082155516 | Lumenis BE inc | $1,178.89 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110645289 | Alcon Vision LLC | $122.19 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111701384 | Amgen Inc. | $24.28 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111701386 | Amgen Inc. | $23.22 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139130998 | Tarsus Pharmaceuticals, Inc. | $73.55 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139131000 | Tarsus Pharmaceuticals, Inc. | $22.62 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139131002 | Tarsus Pharmaceuticals, Inc. | $13.39 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145327046 | Galderma Laboratories, L.P. | $56.84 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.